Product Information
OLANZAPINE ODT 20 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.7222 per EA under NDC 64380017502. Its NADAC has been published 210 times since Sep 28, 2022.
FDA first approved this application on Oct 24, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380017502
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OLANZAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA078109FDA Approved
10/24/2011
TE Code
AB
On Market Since
4/11/2022
Pharmacological Classes
Price Statistics
The NADAC for OLANZAPINE ODT 20 MG TABLET has been published 210 times since Sep 28, 2022, and over the history we have for it it has declined 24.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7222 per EA |
|---|---|
| All-time high | $1.2854 (Jul 12, 2023) |
| All-time low | $0.5656 (Jul 17, 2024) |
| 52-week high | $0.8924 |
| 52-week low | $0.7222 |
| Median price | $0.8042 |
| Average price | $0.8295 |
| Largest weekly change | +54.0% (Jun 21, 2023) |
| Weeks tracked | 210 |
| Tracking since | Sep 28, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the olanzapine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strides Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
olanzapine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OLANZAPINE ODT 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OLANZAPINE ODT 20 MG TABLET, manufactured by Strides Pharma Inc., is $0.7222 per EA (NDC 64380017502), effective Sep 30, 2026.
How has the price of OLANZAPINE ODT 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for OLANZAPINE ODT 20 MG TABLET has declined 24.5%. It has been tracked across 210 weekly CMS publications since Sep 28, 2022.
What are the highest and lowest recorded NADAC prices for OLANZAPINE ODT 20 MG TABLET?
Since Sep 28, 2022, the NADAC for OLANZAPINE ODT 20 MG TABLET has ranged from a low of $0.5656 (Jul 17, 2024) to a high of $1.2854 (Jul 12, 2023), with a median of $0.8042 per EA.
Are there cheaper alternatives to OLANZAPINE ODT 20 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of OLANZAPINE ODT 20 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OLANZAPINE ODT 20 MG TABLET?
OLANZAPINE ODT 20 MG TABLET (NDC 64380017502) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.